Sanofi S.A., FR0000120578

Sanofi stock trades at EUR 71.92 with USD 96.6 billion market value

Published on 10/09/2026 at 15:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sanofi stock costs EUR 71.92 on October 9, 2026 after EUR 71.78, up 0.20 percent. Market value is USD 96.6 billion.

Key points in brief

Sanofi stock was EUR 71.92 at Lang & Schwarz on October 9, 2026, up 0.20 percent from EUR 71.78.
Market capitalization stood at USD 96.6 billion on October 9, 2026.
Jefferies kept a Buy rating and a EUR 100 target on October 7, 2026.
Third-quarter 2026 results are scheduled for October 30, 2026.
AstraZeneca and GSK posted different same-day Nasdaq valuation and performance figures.

Modern pharmaceutical sterile fill-and-finish manufacturing facility interior with glass vial-filling machines and cleanroom workers in white suits — Sanofi FR0000120578 photorealistic sterile fill-and-finish facility with vial-filling machines and cleanroom workers, Illustration mit AI erstellt.

Sanofi stock (ISIN FR0000120578) was trading at EUR 71.92 at Lang & Schwarz on October 9, 2026 at 3:41 p.m. CEST, plus 0.20 percent versus the prior close of EUR 71.78. Market capitalization stood at USD 96.6 billion as of October 9, 2026, putting the company among the larger listed pharmaceutical groups.

Bid ask spread stays narrow

The Lang & Schwarz bid was EUR 71.91 and the ask EUR 71.93 at 3:41 p.m. CEST on October 9, 2026. At the Nasdaq listing, Sanofi traded at USD 40.24 at 9:51 a.m. EDT, up 0.02 percent from USD 40.23, with 159,198 shares traded against an average volume of 2,872,917 shares.

Valuation differs across peers

Sanofi carried a price-to-earnings ratio of 22.16 and a dividend yield of 0.12 percent as of October 9, 2026. The Nasdaq quotation uses ticker SNY, while the Euronext listing uses ticker SAN, according to Boursorama on October 6, 2026.

Jefferies target remains higher

Jefferies maintained its Buy rating and EUR 100 price target for Sanofi on October 7, 2026, according to t-online. The target lies 39.04 percent above the Lang & Schwarz price, calculated from EUR 100.00 and EUR 71.92, so the analyst view provides a separate valuation reference rather than a daily trading signal.

Comparison with peers

Sanofi: plus 0.20 percent, P/E 22.16, market capitalization USD 96.6 billion
AstraZeneca (Nasdaq, USD): plus 0.49 percent, P/E 23.86, market capitalization USD 247.5 billion
GSK (Nasdaq, USD): plus 0.09 percent, P/E 14.79, market capitalization USD 93.3 billion

Results date is October 30

Sanofi is scheduled to review third-quarter 2026 results on October 30, 2026, with a live webcast from 1:30 p.m. to 2:30 p.m. CET, according to the company's investor-relations calendar. The date gives the stock a defined company-specific calendar point while the October 9 quotation supplies the immediate market reference.

Sanofi stock stays near EUR 72

Sanofi's euro quotation remained close to EUR 72 during the October 9, 2026 session, with the daily move limited to plus 0.20 percent versus the October 8, 2026 prior close. The further course of trading is shown by the continuously updated real-time quote of Sanofi stock.